FDA Inspection 1280197 — Abon Pharmaceuticals, LLC
The FDA completed an inspection of Abon Pharmaceuticals, LLC on Aug 6, 2025 in Chestnut Ridge, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 6, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Chestnut Ridge, NY (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)